Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (118) Arrow Down
Filter Results: (118) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (118)
    • People  (1)
    • News  (15)
    • Research  (68)
    • Events  (1)
  • Faculty Publications  (45)

Show Results For

  • All HBS Web  (118)
    • People  (1)
    • News  (15)
    • Research  (68)
    • Events  (1)
  • Faculty Publications  (45)
← Page 3 of 118 Results →
  • 12 Dec 2023
  • Blog Post

Bridging Science and Business: My Summer Internship at Eli Lilly

forecasting the future landscape of gene editing—a field close to my heart. The goal? To pinpoint where Eli Lilly could judiciously invest today to be at the forefront of tomorrow's medical breakthroughs. It wasn't a simple trend-spotting... View Details

    Rosabeth M. Kanter

    Rosabeth Moss Kanter holds the Ernest L. Arbuckle Professorship at Harvard Business School, specializing in strategy, innovation, and leadership for change. Her strategic and practical insights guide leaders worldwide through teaching, writing, and direct... View Details

    Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
    • 14 Jul 2023
    • Blog Post

    Harvard Business School Announces Its 2023-2024 Blavatnik Fellows

    personalized oncology care. They have collectively raised more than $500M in funding and an additional $244M from an IPO in June 2020. The fellowship is guided by Peter Barrett, executive fellow, and a Key Advisory Board of 13 seasoned business and View Details

      William A. Sahlman

      William Sahlman is a Baker Foundation Professor of Business Administration at Harvard Business School.

      Mr. Sahlman received an A.B. degree in Economics from Princeton University (1972), an M.B.A. from Harvard University (1975), and a Ph.D. in Business... View Details

      Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
      • November 2023 (Revised April 2024)
      • Case

      BiomX: Bringing Phage Back to the Stage

      By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
      In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
      Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Biotechnology Industry; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
      • Web

      For Recruiters - Health Care

      systems, e-health firms, pharmaceutical companies, medical device manufacturers, and biotechnology companies. Hire a Summer Intern Summer internships are valuable for both employers and students as a “test... View Details
      • June 2023
      • Case

      Verve Therapeutics: Taking DNA Editing to Heart

      By: Shikhar Ghosh and Shweta Bagai
      Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
      Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
      Citation
      Educators
      Purchase
      Related
      Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
      • Web

      Winners & Runners-Up | New Venture Competition

      of biotechnology by revolutionizing the water treatment industry with our patented, low cost, environmentally friendly process for water demineralization. Elective Medical Lending Boyd Bishop Simon Mattox... View Details

        John T. Gourville

        John Gourville is the Albert J. Weatherhead, Jr. Professor of Business Administration at the Harvard Business School.  He joined the HBS Marketing Unit in 1995 after receiving his Ph.D. at the University of Chicago in marketing and behavioral research.  His most... View Details

        Keywords: biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology; biotechnology
        • Web

        Advisory Board - Entrepreneurship

        investment advisory firm. Mr. Dauten is also the former CEO and President of HIMSCORP, Inc., a medical records storage and retrieval company that he successfully merged with Iron Mountain in 1997. Mr. Dauten currently serves on the Board... View Details
        • 21 Apr 2009
        • First Look

        First Look: April 21, 2009

        this case: http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807106 Note on Biotech Business Development Harvard Business School Note 807-032 Describes the business development process in biotechnology... View Details
        Keywords: Martha Lagace
        • 12 Apr 2022
        • Blog Post

        The Many Languages of Medicine to Impact Care Delivery

        Ted Obi (MS/MBA 2023) is a current MBA student at HBS and a third year medical student at the Icahn School of Medicine at Mount Sinai. His previous experiences include co-founding Melanin Doc, a non-profit supporting the next generation... View Details
        • 01 Oct 2021
        • News

        From Scholarship to Life-Saving Impact

        ending up with huge medical bills we couldn’t pay.” Inspired by this personal experience, Rabah chose to build a career in health care. She studied biology as an undergraduate at Cornell, where she developed a strong interest in drug... View Details
        • 17 Sep 2021
        • Research & Ideas

        The Trial of Elizabeth Holmes: Visionary, Criminal, or Both?

        Former Theranos employees began testifying this week against Elizabeth Holmes, the once-celebrated biotech’s founder and CEO, in a criminal trial that has Silicon Valley worried. In opening statements last week, federal prosecutors charged that Holmes and the company’s... View Details
        Keywords: by Christina Pazzanese, Harvard Gazette; Biotechnology; Biotechnology; Biotechnology
        • Web

        Student Spotlight: 2023 HCC Co-Presidents Reflect on Their Time at HBS and the Current Health Care Systems - Blog: Health Supplement

        Practitioners Topics Topics Biotech/pharma Care Delivery Clinical Trials Digital Health Global Health Health Care Entrepreneurship Health Care Innovation Health Care Investment Health Care at HBS Insurance/payor Medical... View Details
        • 31 Jan 2014
        • News

        Body, Heal Thyself

        messenger RNA (mRNA) Therapeutics. The data that Bancel saw that evening were shocking. The numbers suggested Moderna had found an entirely new way to treat diseases—one that promised to change the medical world, resulting in cures for... View Details
        Keywords: Maureen Harmon; biotech; Health, Social Assistance; Scientific Research and Development Services
        • January 2014 (Revised December 2014)
        • Case

        GenapSys: Business Models for the Genome

        By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble

        GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details

        Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation & Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States
        Citation
        Educators
        Purchase
        Related
        Hamermesh, Richard G., Joseph B. Fuller, and Matthew Preble. "GenapSys: Business Models for the Genome." Harvard Business School Case 814-050, January 2014. (Revised December 2014.)
        • Profile

        Arjun Goyal

        the possibilities, Arjun sought “a better understanding of how to go from lab work to medical product” by taking an internship (after fulfilling his medical residency in Sydney, Australia) with Celtic... View Details
        Keywords: Entrepreneurship; Health Care
        • Web

        Industry Information - Alumni

        biotechnology, drug discovery technologies, clinical diagnostics, healthcare IT, medical imaging, and medical devices, and provide local expertise along with a global perspective. BioSpace Leading online... View Details
        • January 2017
        • Case

        Danaher Corporation, 2007–2017

        By: John R. Wells and Gabriel Ellsworth
        On July 2, 2016, Danaher Corporation completed the spinoff of Fortive Corporation. The previous day, Danaher’s stock price had reached an all-time high. In 2015, Danaher had decided to split off its test and measurement, fuel and fleet management, and automation... View Details
        Keywords: Danaher; Fortive; Larry Culp; Beckman Coulter; Pall; Life Sciences; Diagnostics; Environmental Operations; Water Management; Dental; Testing; Measurement; Fuel; Fleet Management; Automation; Toolmaking; Tools; Disease Management; Continuous Improvement; Toyota Production System; Divestiture; Spinoffs; Spin-off; Networks; Acquisition; Mergers and Acquisitions; Business Conglomerates; Business Divisions; Business Subsidiaries; Business Units; Business Growth and Maturation; Business Model; For-Profit Firms; Joint Ventures; Restructuring; Engineering; Chemicals; Construction; Machinery and Machining; Profit; Revenue; Globalized Firms and Management; Multinational Firms and Management; Health; Health Care and Treatment; Health Disorders; Medical Specialties; Business History; Job Cuts and Outsourcing; Business or Company Management; Growth and Development Strategy; Management Analysis, Tools, and Techniques; Management Practices and Processes; Management Succession; Management Systems; Resource Allocation; Market Entry and Exit; Measurement and Metrics; Logistics; Business Processes; Organizational Change and Adaptation; Public Ownership; Problems and Challenges; Science; Genetics; Natural Environment; Wastes and Waste Processing; Science-Based Business; Opportunities; Strategy; Adaptation; Business Strategy; Competition; Competitive Strategy; Competitive Advantage; Consolidation; Corporate Strategy; Diversification; Expansion; Technology; Software; Technology Networks; Technology Platform; Value; Valuation; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; Biotechnology Industry; United States; District of Columbia
        Citation
        Educators
        Purchase
        Related
        Wells, John R., and Gabriel Ellsworth. "Danaher Corporation, 2007–2017." Harvard Business School Case 717-464, January 2017.
        • ←
        • 3
        • 4
        • 5
        • 6
        • →
        ǁ
        Campus Map
        Harvard Business School
        Soldiers Field
        Boston, MA 02163
        →Map & Directions
        →More Contact Information
        • Make a Gift
        • Site Map
        • Jobs
        • Harvard University
        • Trademarks
        • Policies
        • Accessibility
        • Digital Accessibility
        Copyright © President & Fellows of Harvard College.